STAT
JUNE 27, 2024
The U.S. Supreme Court rejected a controversial bankruptcy deal in which the owners of Purdue Pharma sought to contribute up to $6 billion in exchange for immunity from further lawsuits. The ruling means the company and its creditors — numerous states, cities and counties, as well as Native American governments — will have to negotiate a new settlement.
PharmaVoice
JUNE 27, 2024
Neuroscience pipelines are reawakening as biotechs prove to the pharma giants that the field is still worth the investment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 27, 2024
In the pit of the pandemic, with no one to see and nowhere to go, and horrors unfolding daily outside the front door, there was for many a reliable bright spot: the 5 p.m. drink that would mark the end of the workday. Drinking, which was already on the rise before 2020, became a coping mechanism for overburdened parents, burnt-out workers, the traumatized, and the bored.
PharmaVoice
JUNE 27, 2024
Obesity drugs like Wegovy are proving useful in many other diseases. Polycystic ovary syndrome, a chronic condition that can cause infertility, may be one.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 27, 2024
WASHINGTON — Mike Leavitt is in the small club of government officials who’ve led an avian flu response. The experience is still fresh in his mind nearly two decades later. When he first heard about the avian flu outbreak in 2005, he had been secretary of health and human services in George W. Bush’s administration for just a couple of months.
BioPharma Dive
JUNE 27, 2024
A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
JUNE 27, 2024
Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective management of drug patent portfolios requires strategic planning, ongoing evaluation, and adaptation to the evolving pharmaceutical landscape. This article explores key best practices for optimizing drug patent portfolios to maximize value and maintain competitive advantage.
STAT
JUNE 27, 2024
As a Canadian-born physician who has treated people with opioid use disorder on both sides of the U.S.-Canada border, I know that if I ever needed addiction treatment I’d head to the Great White North. Deaths from drug overdoses are twice as high in the U.S. as in Canada. Some of that difference stems from how people with opioid use disorder are treated in the two countries.
Outsourcing Pharma
JUNE 27, 2024
The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives.
STAT
JUNE 27, 2024
Google’s recent integration of Gemini, its state-of-the-art large language model, into its search engine marks a significant step in AI-driven responses for digital health queries. Worldwide, users search Google with health queries 70,000 times per minute , so it has years of experience in communicating health information and a solid framework for producing high quality, authoritatively sourced responses for users.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
JUNE 27, 2024
Novo will pay $38 million in cash under the deal, which will also see 2seventy employees working on the program transfer to the Danish drugmaker.
STAT
JUNE 27, 2024
BEVERLY HILLS, Calif. — Artificial intelligence is increasingly infused into many aspects of health care, from transcribing patient visits to detecting cancers and deciphering histology slides. While AI has the potential to improve the drug discovery process and help doctors be more empathetic towards patients, it can also perpetuate bias , and be used to deny critical care to those who need it the most.
Express Pharma
JUNE 27, 2024
Mohan Babu University’s School of Pharmaceutical Sciences hosted the national conference – IRPBMS 2024 on “Bridging the Gap Between Academia and Industry in Health Sciences.” This three-day event brought together leading researchers, academicians, healthcare professionals, and industry experts to discuss enhancing collaboration, aligning research goals, and promoting innovation.
STAT
JUNE 27, 2024
A startup selling elective whole-body scans for upward of $1,000 is launching a 10-year, 100,000 person study to attempt to settle doubts within the medical community about its value and potential consequences. Prenuvo, the Redwood City, Calif.-based startup touted last year by Kim Kardashian , is one of a handful of companies selling preventive MRI scans: images that aim to catch conditions like cancer, brain aneurysms, autoimmune disorders, and metabolic issues before they advance.
The Pharmacist
JUNE 27, 2024
The president of the Primary Care Pharmacy Association (PCPA) has said he 'would not wish' Additional Roles Reimbursement Scheme (ARRS) or Pharmacy First funding 'to be subsumed' into core general practice funding, as called for recently by the Doctors' Association UK (DAUK). In a 10-point manifesto presented to prospective MPs last week, the DAUK’s GP […] The post PCPA president defends multidisciplinary team as doctors ask for ARRS funding appeared first on The Pharmacist.
STAT
JUNE 27, 2024
WASHINGTON — The Supreme Court on Thursday released an opinion allowing emergency abortions in Idaho but avoiding the larger question of state abortion bans. It’s the final version of an opinion that was inadvertently released on Wednesday. The 6-3 decision lifts a stay on a previous court’s order to allow abortions in rare but life-threatening circumstances.
pharmaphorum
JUNE 27, 2024
Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster.The first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years, according to Verona.
STAT
JUNE 27, 2024
Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy? And what health care issues may be lightening rods in this election? STAT chief Washington correspondent Rachel Cohrs Zhang joins the podcast to talk about a new proposal for obesity drug coverage in Washington and what to expect from the first presidential debate. STAT health tech reporter Brittany Trang also guest co-hosts “The Readout LOUD” this week, where we discuss AI for drug development, the la
pharmaphorum
JUNE 27, 2024
Explore a methodological approach for discovering the emotional patient journey through patient insights. Understand the importance of emotional connections in healthcare.
STAT
JUNE 27, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Read on today for some exclusive hiring news and a retraction of a high-profile paper on cancer detection.
Outsourcing Pharma
JUNE 27, 2024
Artificial intelligence is showing great promise in the quest to unearth new drug candidates and disease targets faster than ever before.
STAT
JUNE 27, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Hospital at home creeps towards commercial New Jersey-based Hackensack Meridian Health this week announced it will gradually expand its hospital at home program from three of its larger facilitates, to its entire system of 18 hospitals, illustrating growing
Outsourcing Pharma
JUNE 27, 2024
Personalized medicine has evolved to the point where it is transforming areas of healthcare, bringing hope to patients across the world.
STAT
JUNE 27, 2024
Good morning, everyone, and how are you today? The heat continues to rise here on the Pharmalot campus, where we are hoping for storm clouds to wash away the humidity that has characterized the past few days. One can dream, yes? To cope, we are quaffing some cups of stimulation — our choice today is butter pecan — and distracting ourselves by foraging for items of interest.
The Pharmacist
JUNE 27, 2024
A steady decline in children’s health over the past two decades in the UK means they are now shorter and more likely to have obesity and type 2 diabetes. A report from the Food Foundation found the height of five-year olds has been falling since 2013, with UK children now shorter than those in nearly […] The post UK children shorter, more obese and less healthy than 20 years ago appeared first on The Pharmacist.
STAT
JUNE 27, 2024
Walgreens is finalizing a plan to fix its U.S. business that could result in closing hundreds of additional stores over the next three years. CEO Tim Wentworth told analysts Thursday morning that “changes are imminent” for about 25% of the company’s stores, which he said were underperforming. The drugstore chain currently runs more than 8,600 in the United States.
Express Pharma
JUNE 27, 2024
Alkem Laboratories announced the completion of the inspection at its manufacturing facility in Baddi, Himachal Pradesh. The United States Food and Drug Administration (US FDA) issued an Establishment Inspection Report (EIR) for the manufacturing facility. The Inspection was classified as Voluntary Action Indicated (VAI), following which the inspection was properly closed The establishment was examined by the US FDA on March 27, 2024.
pharmaphorum
JUNE 27, 2024
CSL Behring's gene therapy Hemgenix for haemophilia B has been backed for reimbursement in England and Denmark.
Pharmaceutical Technology
JUNE 27, 2024
Data showed that Ohtuvayre significantly improved dyspnea compared to placebo in as little as six weeks and maintained this over 24 weeks.
pharmaphorum
JUNE 27, 2024
SCOTUS rejects bankruptcy deal that would settle opioid litigation against Purdue Pharma, but also protect the Sackler family from liability.
Pharmaceutical Technology
JUNE 27, 2024
NovoNordisk acquired the hypertension and kidney disease drug ocedurenone from KBP Biosciences in 2023 as part of a $1.3bn deal.
pharmaphorum
JUNE 27, 2024
Unleash the power of generative AI (GenAI) in the pharmaceutical industry to achieve excellence in product launch strategies. Learn how this cutting-edge technology can drive your business forward.
The Pharmacist
JUNE 27, 2024
Long-awaited new draft UK joint guidelines on asthma care overhauls recommended diagnostics and treatment, but the review committee warned they will require ‘significant investment’. Draft NICE/BTS/SIGN guidelines on diagnosis, monitoring and management of asthma recommends significant changes to current treatment approaches, including replacing the use of short-acting beta agonist (SABA) alone with combined inhaled corticosteroid (ICS)/formoterol […] The post Long-awaited joint asthma gui
pharmaphorum
JUNE 27, 2024
FDA rejects MSD, Daiichi Sankyo’s HER3-targeted ADC patritumab deruxtecan because of problems at a third-party manufacturer
Express Pharma
JUNE 27, 2024
Lupin announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 per cent (OTC), to market a generic equivalent of Pataday Once Daily Relief, 0.7 per cent (OTC), of Alcon Laboratories. This product will be manufactured at Lupin’s Pithampur facility in India.
Expert insights. Personalized for you.
353 
Let's personalize your content